Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Change in Taxes: 2013-2024

Historic Change in Taxes for Ani Pharmaceuticals (ANIP) over the last 12 years, with Dec 2024 value amounting to -$1.4 million.

  • Ani Pharmaceuticals' Change in Taxes fell 287.64% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year increase of 53.01%. This contributed to the annual value of -$1.4 million for FY2024, which is 111.80% down from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Change in Taxes is -$1.4 million, which was down 111.80% from $12.0 million recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Change in Taxes registered a high of $12.0 million during FY2023, and its lowest value of -$7.6 million during FY2021.
  • Over the past 3 years, Ani Pharmaceuticals' median Change in Taxes value was -$160,000 (recorded in 2022), while the average stood at $3.5 million.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Change in Taxes tumbled by 252.01% in 2021, and later surged by 7,594.37% in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Change in Taxes (Yearly) stood at $5.0 million in 2020, then tumbled by 252.01% to -$7.6 million in 2021, then surged by 97.89% to -$160,000 in 2022, then skyrocketed by 7,594.37% to $12.0 million in 2023, then crashed by 111.80% to -$1.4 million in 2024.